Onychomycosis (Tinea Unguium) Drug  Market Report

Global and China Onychomycosis (Tinea Unguium) Drug  Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 25, 2022
  • PAGES：211
  • REPORT CODE：GMM1492296
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Onychomycosis (Tinea Unguium) Drug  industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Qilu Pharmaceutical

    • Letai

    • Novartis

    • Pfizer

    • Valeant Pharma

    • GSK

    • Xiuzheng Pharmaceutical

    • Kaken Pharmaceutical

    • Johnson and Johnson

    • Galderma

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral Medication

    • External Medicine

    Application:

    • Age under 18

    • Age 18-50

    • Age above 50

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Onychomycosis (Tinea Unguium) Drug  Industry Overview

      • 1.1.1 Onychomycosis (Tinea Unguium) Drug  Market Scope and Market Segments

      • 1.1.2 Onychomycosis (Tinea Unguium) Drug  Industry Characteristics

      • 1.1.3 Global and China Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Onychomycosis (Tinea Unguium) Drug  Production Value and Growth Rate (2017-2028)

    • 1.2 Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral Medication

      • 1.2.2 External Medicine

    • 1.3 Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Age under 18

      • 1.3.2 Age 18-50

      • 1.3.3 Age above 50

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Onychomycosis (Tinea Unguium) Drug  Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Onychomycosis (Tinea Unguium) Drug  Industry Porter's Five Forces Model Analysis

      • 2.2.3 Onychomycosis (Tinea Unguium) Drug  Industry PEST Analysis

    • 2.3 Onychomycosis (Tinea Unguium) Drug  Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Onychomycosis (Tinea Unguium) Drug  Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Onychomycosis (Tinea Unguium) Drug  Industry

    Chapter 3 Global and China Onychomycosis (Tinea Unguium) Drug  Market, by Manufacturer

    • 3.1 Global and China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Onychomycosis (Tinea Unguium) Drug  Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Onychomycosis (Tinea Unguium) Drug  Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Onychomycosis (Tinea Unguium) Drug  Market Top 3 Players

    Chapter 4 Global and China Onychomycosis (Tinea Unguium) Drug  Market, by Type (2017-2028)

    • 4.1 Onychomycosis (Tinea Unguium) Drug  Market Trend, by Type

    • 4.2 Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Onychomycosis (Tinea Unguium) Drug  Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Onychomycosis (Tinea Unguium) Drug  Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Onychomycosis (Tinea Unguium) Drug  Price Trend, by Type (2017-2028)

    • 4.3 China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Onychomycosis (Tinea Unguium) Drug  Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Onychomycosis (Tinea Unguium) Drug  Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Onychomycosis (Tinea Unguium) Drug  Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Onychomycosis (Tinea Unguium) Drug  Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Onychomycosis (Tinea Unguium) Drug  Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Onychomycosis (Tinea Unguium) Drug  Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Onychomycosis (Tinea Unguium) Drug  Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Onychomycosis (Tinea Unguium) Drug  Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Onychomycosis (Tinea Unguium) Drug  Market Analysis

    • 7.1 North America Onychomycosis (Tinea Unguium) Drug  Market, by Type

    • 7.2 North America Onychomycosis (Tinea Unguium) Drug  Market, by Application

    • 7.3 North America Onychomycosis (Tinea Unguium) Drug  Market Analysis and Forecast, by Country

      • 7.3.1 United States Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Onychomycosis (Tinea Unguium) Drug  Market Analysis

    • 8.1 Europe Onychomycosis (Tinea Unguium) Drug  Market, by Type

    • 8.2 Europe Onychomycosis (Tinea Unguium) Drug  Market, by Application

    • 8.3 Europe Onychomycosis (Tinea Unguium) Drug  Market Analysis and Forecast, by Country

      • 8.3.1 Germany Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Onychomycosis (Tinea Unguium) Drug  Market Analysis

    • 9.1 APAC Onychomycosis (Tinea Unguium) Drug  Market, by Type

    • 9.2 APAC Onychomycosis (Tinea Unguium) Drug  Market, by Application

    • 9.3 APAC Onychomycosis (Tinea Unguium) Drug  Market Analysis and Forecast, by Country

      • 9.3.1 China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Market Analysis

    • 10.1 Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Market, by Type

    • 10.2 Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Market, by Application

    • 10.3 Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Onychomycosis (Tinea Unguium) Drug  Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Onychomycosis (Tinea Unguium) Drug  Company Profiles

      • 11.1 Qilu Pharmaceutical

        • 11.1.1 Qilu Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.1.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Letai

        • 11.2.1 Letai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Letai Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.2.3 Letai Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Novartis

        • 11.3.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Novartis Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.3.3 Novartis Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Pfizer

        • 11.4.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Pfizer Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Valeant Pharma

        • 11.5.1 Valeant Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GSK

        • 11.6.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GSK Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.6.3 GSK Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Xiuzheng Pharmaceutical

        • 11.7.1 Xiuzheng Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.7.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Kaken Pharmaceutical

        • 11.8.1 Kaken Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.8.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Johnson and Johnson

        • 11.9.1 Johnson and Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.9.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Galderma

        • 11.10.1 Galderma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Galderma Onychomycosis (Tinea Unguium) Drug  Product Profiles, Application and Specification

        • 11.10.3 Galderma Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Onychomycosis (Tinea Unguium) Drug  Industry Investment Prospect and Risk Assessment

    • 12.1 Onychomycosis (Tinea Unguium) Drug  Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Onychomycosis (Tinea Unguium) Drug  Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Production Value and Growth Rate (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Production Value and Growth Rate (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate of Oral Medication (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate of External Medicine (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate of Age under 18 (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate of Age 18-50 (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Market Size and Growth Rate of Age above 50 (2017-2028)

    • Figure North America Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Onychomycosis (Tinea Unguium) Drug  Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Onychomycosis (Tinea Unguium) Drug  Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Onychomycosis (Tinea Unguium) Drug  Market Share, by Manufacturer in 2021

    • Figure Global and China Onychomycosis (Tinea Unguium) Drug  Market Share, by Manufacturer in 2022

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Type (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Value, by Type (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Value Share, by Type (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Price Trend, by Type (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Type (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Value, by Type (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Value Share, by Type (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Price Trend, by Type (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Application (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Value, by Application (2017-2028)

    • Table Global Onychomycosis (Tinea Unguium) Drug  Sales Value Share, by Application (2017-2028)

    • Figure Global Onychomycosis (Tinea Unguium) Drug  Sales Value Share, by Application (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Application (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Value, by Application (2017-2028)

    • Table China Onychomycosis (Tinea Unguium) Drug  Sales Value Share, by Application (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Value Share, by Application (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • Figure North America Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Production, Import, Consumption and Export (2017-2022)

    • Table North America Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Type (2017-2028)

    • Table North America Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Figure North America Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Table North America Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Application (2017-2028)

    • Table North America Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure North America Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure United States Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure United States Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Canada Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Type (2017-2028)

    • Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Application (2017-2028)

    • Table Europe Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure Europe Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure Germany Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure UK Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure UK Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure France Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure France Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Italy Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Spain Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Poland Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Russia Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Table APAC Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Type (2017-2028)

    • Table APAC Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Figure APAC Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Table APAC Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Application (2017-2028)

    • Table APAC Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure APAC Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure China Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Japan Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure India Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure India Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Onychomycosis (Tinea Unguium) Drug  Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Onychomycosis (Tinea Unguium) Drug  Sales Value and Growth Rate (2017-2028)

    • Table Qilu Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qilu Pharmaceutical Product Profiles, Application and Specification

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Letai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Letai Product Profiles, Application and Specification

    • Table Letai Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharma Product Profiles, Application and Specification

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Xiuzheng Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Xiuzheng Pharmaceutical Product Profiles, Application and Specification

    • Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kaken Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kaken Pharmaceutical Product Profiles, Application and Specification

    • Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson and Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson and Johnson Product Profiles, Application and Specification

    • Table Johnson and Johnson Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Galderma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Galderma Product Profiles, Application and Specification

    • Table Galderma Onychomycosis (Tinea Unguium) Drug  Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US